All In MedTech

Device type · KLI

Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about KLI: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

KLI

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

1

510(k), De Novo and PMA

Adverse event reports

93

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine
Product code
KLI
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1700

Latest FDA decisions

All decisions for KLI

Reports received

93

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

93

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 240000
Mar 240000
Apr 240000
May 240000
Jun 240000
Jul 240000
Aug 240000
Sep 240000
Oct 240000
Nov 240000
Dec 240000
Jan 250000
Feb 250000
Mar 250000
Apr 250000
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 260000
Jul 260000
Aug 260000
Sep 260000
Oct 2693000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results87
  • Imprecise or Erratic Results6

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions60
  • Insufficient Information17
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available16

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Beckman Coulter, Inc.

    Z-1922-2026 · Started Mar 16, 2026 · Posted by FDA Apr 22, 2026

    Reason given: Beckman Coulter has identified that Access Total T4 Calibrator lots (PN 33805) exhibit a negative bias on DxI 600/800 instruments, with slopes outside product specifications. A false low patient result could cause a patient to undergo unnecessary additional diagnostic testing. A patient may be treated for a disorder...

    Cause as FDA categorized it: Nonconforming Material/Component

  • Beckman Coulter, Inc.

    Z-1303-2024 · Started Feb 8, 2024 · Posted by FDA Mar 15, 2024

    Reason given: Four lots of Access Total T4 reagent lots demonstrated imprecision outside of the 10% specification which may result in erroneous or delayed results.

    Cause as FDA categorized it: Vendor change control

  • DRG International, Inc.

    Z-0310-2022 · Started Oct 18, 2021

    Reason given: Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.

    Cause as FDA categorized it: Nonconforming Material/Component

9 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.